This item is testing the idea that stress is a dynamic process shaped by the demands placed on a person and the resources available to meet them. Pearlin’s stress process model describes stress as an ongoing interaction where internal demands (like personal roles and expectations) and external demands (such as work, caregiving, or family strains) create stressors, while resources (coping skills, social support, finances) help buffer or mediate their impact. How a person appraises these demands and uses resources to cope influences health and well-being over time, which is why this theory best fits the description of stress as a process involving internal and external demands and resources. In contrast, the stimulus view treats stress as a count of life events, the transaction view centers on appraisal of the situation, and the response view focuses on physiological reactions to stressors, rather than the ongoing resource-mediated process.

Pharmacology can support stress management in cancer care by using medications to ease anxiety, improve sleep, and stabilize mood when these symptoms are distressing or interfere with treatment and daily functioning. Nonpharmacologic approaches like counseling, mindfulness, and sleep hygiene are essential, but medications provide an important option when symptoms persist or are severe enough to impact adherence to therapy or quality of life. Anxiolytics can offer rapid relief of acute anxiety, which can help patients engage in treatment and coping strategies, yet they come with considerations such as daytime sedation, cognitive effects, potential dependence, and interactions with other medications. Antidepressants, including selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors, can help with ongoing anxiety and depressive symptoms as well as energy and mood, but they require several weeks to take full effect and may interact with chemotherapy, antiemetics, or other drugs. Sleep medications can help with cancer-related insomnia, but the goal is to minimize daytime impairment and avoid masking fatigue or causing next-day sedation. Choosing pharmacologic therapy involves evaluating the individual’s overall treatment plan, organ function, and potential drug interactions, and it should be done in coordination with the oncology team. The aim is to use the lowest effective dose for the shortest appropriate duration while monitoring for side effects and reassessing as cancer treatment progresses. In short, medications can be a valuable part of stress management when used thoughtfully and safely alongside nonpharmacologic strategies.

During the alarm stage of the GAS, the brain activates the hypothalamic-pituitary-adrenal (HPA) axis. The hypothalamus releases corticotropin-releasing hormone (CRH), which stimulates the anterior pituitary to secrete adrenocorticotropic hormone (ACTH). ACTH then travels to the adrenal cortex, prompting cortisol release to mobilize energy and support the stress response. The anterior pituitary is the source of ACTH in this cascade, not the hypothalamus (which releases CRH upstream), nor the adrenal cortex (which releases cortisol in response to ACTH), nor the adrenal medulla (which releases catecholamines).

Environmental modifications to reduce hospital stress rely on creating a calm, predictable environment and ensuring supportive interactions with caregivers. Scheduling caregiving to minimize disruption helps patients feel safe because routines are predictable, and explanations about care reduce uncertainty and anxiety. Reducing noise supports comfort and concentration. In contrast, avoiding any caregiver contact removes essential reassurance and social support, making stress worse. This is why that option doesn’t fit the approach used to ease stress in the hospital.